(Q52017663)

19 April 2018

title

Chronic inflammation in Alzheimer's disease offers therapeutic opportunities. (English)

1 reference

19 April 2018

0 references

0 references

E G McGeer

1

1 reference

19 April 2018

P L McGeer

series ordinal

2

1 reference

19 April 2018

publication date

1 September 2001

1 reference

19 April 2018

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

published in

1 reference

19 April 2018

volume

1

1 reference

19 April 2018

issue

1

1 reference

19 April 2018

page(s)

53-60

1 reference

19 April 2018

Immuno-electron-microscopic localization of complements in amyloid fibrils of senile plaques.

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.1.53

Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.1.53

Autotoxicity and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.1.53

Association of amyloid P component with complement proteins in neurologically diseased brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.1.53

Brain microglia constitutively express beta-2 integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.1.53

Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.1.53

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.1.53

Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.1.53

Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.1.53

Alpha-2 macroglobulin is genetically associated with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.1.53

Re: Genetic effect of alpha 1-antichymotrypsin on the risk of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.1.53

Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.1.53

Serum amyloid P immunoreactivity in hippocampal tangles, plaques and vessels: implications for leakage across the blood-brain barrier in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.1.53

Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.1.53

Up-regulated production and activation of the complement system in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.1.53

Generation of C-reactive protein and complement components in atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.1.53

Is aspirin underused in myocardial infarction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.1.1.53

21 January 2018

Identifiers

DOI

10.1586/14737175.1.1.53

1 reference

19 April 2018

1 reference

19 April 2018